Zbornik Radova Pravnog Fakulteta u Splitu : Impact Factor & More
eISSN: 1847-0459pISSN: 0584-9063
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Zbornik Radova Pravnog Fakulteta u Splitu Journal Specifications
Indexed in the following public directories
DOAJ
| Overview | |
| Publisher | Pravni fakultet Sveučilišta u Splitu |
| Language | Serbian,English,Croatian |
| Publication Time | 10 |
| Editorial Review Process | Double anonymous peer review |
| General Details | |
| Language | Serbian,English,Croatian |
| Society/Institute/Sponsor | Pravni fakultet Sveučilišta u Splitu |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 10 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in Zbornik Radova Pravnog Fakulteta u Splitu ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Zbornik Radova Pravnog Fakulteta u Splitu
CDK6 inactivation counteracts CALR\u2010mutant\u2010induced MPN evolution and sensitizes MPN stem cells to interferon\u2010\u03b1 treatment
- 12 May 2026
- HemaSphere
The rearrangement partner and the presence of MYC mutations determine the outcome of patients with MYC and BCL6 rearrangements
- 12 May 2026
- HemaSphere
Outcomes and salvage strategies for large B-cell lymphoma progressing after second-line CAR T-cell therapy: A DESCAR-T study from the LYSA group.
- 1 May 2026
- HemaSphere
Factors associated with response to rituximab in patients with immune thrombocytopenia.
- 1 May 2026
- HemaSphere
Fitusiran treatment modulates the ratio between alpha- and beta-antithrombin isoforms.
- 1 May 2026
- HemaSphere
A single JAK2-V617F hematopoietic stem cell can initiate myeloproliferative neoplasm when transplanted into non-conditioned recipient mice.
- 1 May 2026
- HemaSphere
CDK6 inactivation counteracts CALR\u2010mutant\u2010induced MPN evolution and sensitizes MPN stem cells to interferon\u2010\u03b1 treatment
- 12 May 2026
- HemaSphere
The rearrangement partner and the presence of MYC mutations determine the outcome of patients with MYC and BCL6 rearrangements
- 12 May 2026
- HemaSphere
Outcomes and salvage strategies for large B-cell lymphoma progressing after second-line CAR T-cell therapy: A DESCAR-T study from the LYSA group.
- 1 May 2026
- HemaSphere
Factors associated with response to rituximab in patients with immune thrombocytopenia.
- 1 May 2026
- HemaSphere
Fitusiran treatment modulates the ratio between alpha- and beta-antithrombin isoforms.
- 1 May 2026
- HemaSphere
A single JAK2-V617F hematopoietic stem cell can initiate myeloproliferative neoplasm when transplanted into non-conditioned recipient mice.
- 1 May 2026
- HemaSphere
FAQs on Zbornik Radova Pravnog Fakulteta u Splitu
How many articles did Zbornik Radova Pravnog Fakulteta u Splitu publish last year? 
What is the eISSN & pISSN for Zbornik Radova Pravnog Fakulteta u Splitu?
Who is the publisher of Zbornik Radova Pravnog Fakulteta u Splitu?
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary
Your document is 100% secure & confidential We use 256-bit encryption for total security and
ISO/IEC 27001:2013 Certified
What all does the report include
01. Degree of Match
02. Common Topics
03. Additional
Recommendations
Recommendations